Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats (2022)
Source: Plos One. Unidades: FCF, FM
Subjects: NANOPARTÍCULAS, DIÁLISE PERITONEAL
ABNT
SILVA, Filipe Miranda Oliveira et al. Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats. Plos One, v. 17, n. 5, p. 1-15 art. e0268197, 2022Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0268197. Acesso em: 28 out. 2024.APA
Silva, F. M. O., Carvalho, P. O. de, Costalonga, E. C., Pepineli, R., Maranhão, R. C., & Noronha, I. de L. (2022). Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats. Plos One, 17( 5), 1-15 art. e0268197. doi:10.1371/journal.pone.0268197NLM
Silva FMO, Carvalho PO de, Costalonga EC, Pepineli R, Maranhão RC, Noronha I de L. Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats [Internet]. Plos One. 2022 ; 17( 5): 1-15 art. e0268197.[citado 2024 out. 28 ] Available from: https://doi.org/10.1371/journal.pone.0268197Vancouver
Silva FMO, Carvalho PO de, Costalonga EC, Pepineli R, Maranhão RC, Noronha I de L. Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats [Internet]. Plos One. 2022 ; 17( 5): 1-15 art. e0268197.[citado 2024 out. 28 ] Available from: https://doi.org/10.1371/journal.pone.0268197